Vanda Pharmaceuticals (VNDA) Free Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 31.42% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -53.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -53.10% |
| Dec 31, 2025 | -73.53% |
| Sep 30, 2025 | -65.16% |
| Jun 30, 2025 | -69.06% |
| Mar 31, 2025 | -118.68% |
| Dec 31, 2024 | -27.58% |
| Sep 30, 2024 | -52.79% |
| Jun 30, 2024 | -33.44% |
| Mar 31, 2024 | -5.86% |
| Dec 31, 2023 | -30.40% |
| Sep 30, 2023 | -30.59% |
| Jun 30, 2023 | -36.76% |
| Mar 31, 2023 | 199.28% |
| Dec 31, 2022 | -1.99% |
| Sep 30, 2022 | 30.54% |
| Jun 30, 2022 | -35.27% |
| Mar 31, 2022 | -24.56% |
| Dec 31, 2021 | 20.21% |
| Sep 30, 2021 | 3.20% |
| Jun 30, 2021 | 63.08% |
| Mar 31, 2021 | 82.01% |
| Dec 31, 2020 | 77.57% |
| Sep 30, 2020 | 71.90% |
| Jun 30, 2020 | 117.23% |
| Mar 31, 2020 | 39.69% |
| Dec 31, 2019 | 92.85% |
| Sep 30, 2019 | 107.12% |
| Jun 30, 2019 | 101.72% |
| Mar 31, 2019 | 57.25% |
| Dec 31, 2018 | 153.26% |
| Sep 30, 2018 | 51.75% |
| Jun 30, 2018 | -28.78% |
| Mar 31, 2018 | -31.96% |
| Dec 31, 2017 | 30.82% |
| Sep 30, 2017 | 30.74% |
| Jun 30, 2017 | 57.25% |
| Mar 31, 2017 | 37.62% |
| Dec 31, 2016 | 46.46% |
| Sep 30, 2016 | 27.29% |
| Jun 30, 2016 | 26.13% |
| Mar 31, 2016 | 18.79% |
| Dec 31, 2015 | 57.42% |
| Sep 30, 2015 | 17.46% |
| Jun 30, 2015 | 43.68% |
| Mar 31, 2015 | 34.86% |
| Dec 31, 2014 | -3.35% |
| Sep 30, 2014 | -2.03% |
| Jun 30, 2014 | -87.28% |
| Mar 31, 2014 | -94.56% |
| Dec 31, 2013 | -33.96% |
| Sep 30, 2013 | -26.53% |